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Metabolic syndrome is defined as a cluster of cardiovascular and metabolic disorders. 
Previous studies in rat models of metabolic syndrome have demonstrated that ligands 
selective for I1 imidazoline receptor (LNPs) increase insulin sensitivity through central 
sympathoinhibition and an additional peripheral effect attributable to adiponectin, a major 
insulin-sensitizer adipokine. The objective of this study was to explore possible direct actions 
on hepatocytes, one of the target cells of insulin and adiponectin. 
 
Experiments were carried out in HepG2 cells, a cell line of hepatocytes. In order to evaluate 
the effect of LNPs on insulin sensitivity, the activation (i.e. phosphorylation) of a key actor of 
insulin pathways, AKT, was evaluated by measuring the ratio pAKT/AKT by Western Blot. 
Similarly, the effect of LNPs on adiponectin signaling was evaluated by measuring the rate of 
phosphorylation of the central kinase involved in adiponectin pathways, AMPK, by Western 
Blot. Insulin (10 μM) induced the phosphorylation of AKT (pAKT/AKT=0.49±0.16) compared 
to control without insulin (pAKT/AKT=0.11±0.03; p≤0.05) whereas LNPs (1μM) alone did not. 
Interestingly, pretreatment by LNPs (1 μM) during 60 min could potentiate the insulin-
induced activation of AKT: LNP509: pAKT/AKT=1.13±0.18 (p≤0.05 vs insulin alone); LNP599: 
pAKT/AKT=1.23±0.16 (p=0.0545 vs insulin alone). 
 
Concerning adiponectin signaling pathways, LNPs alone (from 10−9M to 10−4M) increased 
AMPK phosphorylation in a concentration- and time-dependent manner. The maximal effect 
was obtained after 10 min exposure of LNPs 10 μM (untreated cells: 
pAMPK/AMPK=0.18±0.04; LNP 509 pAMPK/AMPK=0.38±0.05 p≤0.05; LNP599 
pAMPK/AMPK=0.46±0.17). These datasuggest that LNPs on hepatic cells activate adiponectin 
pathways and potentiate insulin action. These two direct effects on insulin sensitive cells 
could account for the ameliorated insulin sensitivity observed in vivo. 
